Literature DB >> 2419908

Human protein HC and its IgA complex are inhibitors of neutrophil chemotaxis.

E Méndez, J L Fernández-Luna, A Grubb, F Leyva-Cobián.   

Abstract

Protein HC, a heterogeneously charged low molecular weight glycoprotein, and its IgA complex were isolated from human plasma and urine. Plasma from individuals with monoclonal IgA populations was used as starting material for the isolation of the protein HC-IgA complex to obtain homogeneous complex populations. Neither low molecular weight protein HC nor its IgA complex in the concentrations 30 and 600 mg/liter influenced the random migration of normal human neutrophils. The chemotactic response of neutrophils to endotoxin-activated serum was, however, attenuated in a dose-dependent way by both low molecular weight protein HC and protein HC-IgA complex. Concentrations of protein HC and its IgA complex producing significant inhibition of the chemotactic response were found to occur in plasma from healthy and diseased individuals as well as in synovial fluid from patients with rheumatoid arthritis. These results suggest that protein HC and its IgA complex play physiological roles in the regulation of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419908      PMCID: PMC323098          DOI: 10.1073/pnas.83.5.1472

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A functional differentiation of human neutrophil granules: generation of C5a by a specific (secondary) granule product and inactivation of C5a by azurophil (primary) granule products.

Authors:  D G Wright; J I Gallin
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  A complex-forming glycoprotein heterogeneous in charge and present in human plasma, urine, and cerebrospinal fluid.

Authors:  L Tejler; A O Grubb
Journal:  Biochim Biophys Acta       Date:  1976-07-19

4.  Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.

Authors:  R Snyderman; L C Altman; M S Hausman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

5.  A heated Biuret-Folin protein assay which gives equal absorbance with different proteins.

Authors:  T E Dorsey; P W McDonald; O A Roels
Journal:  Anal Biochem       Date:  1977-03       Impact factor: 3.365

6.  A urinary and plasma alpha1-glycoprotein of low molecular weight: isolation and some properties.

Authors:  B Ekström; P A Peterson; I Berggård
Journal:  Biochem Biophys Res Commun       Date:  1975-08-18       Impact factor: 3.575

7.  Human alpha1-microglobulin. Purification procedure, chemical and physiochemical properties.

Authors:  B Ekström; I Berggård
Journal:  J Biol Chem       Date:  1977-11-25       Impact factor: 5.157

8.  Chemotactic factor inactivator in normal human serum.

Authors:  J L Berenberg; P A Ward
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

9.  T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency.

Authors:  J L Touraine; F Touraine; J P Revillard; J Brochier; J Traeger
Journal:  Nephron       Date:  1975       Impact factor: 2.847

10.  Suppression of leukocyte chemotaxis by human IgA myeloma components.

Authors:  D E Van Epps; R C Williams
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  10 in total

Review 1.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

2.  The mRNA for a proteinase inhibitor related to the HI-30 domain of inter-alpha-trypsin inhibitor also encodes alpha-1-microglobulin (protein HC).

Authors:  J F Kaumeyer; J O Polazzi; M P Kotick
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

Review 3.  Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases.

Authors:  M Kilian; J Mestecky; M W Russell
Journal:  Microbiol Rev       Date:  1988-06

4.  Isolation and characterization of cDNAs encoding the heavy chain of human inter-alpha-trypsin inhibitor (I alpha TI): unambiguous evidence for multipolypeptide chain structure of I alpha TI.

Authors:  J P Salier; M Diarra-Mehrpour; R Sesboue; J Bourguignon; R Benarous; I Ohkubo; S Kurachi; K Kurachi; J P Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Measurement of protein HC (alpha 1 microglobulin) and protein HC-IgA complex in different body fluids.

Authors:  J L Fernández-Luna; F Leyva-Cobián; E Méndez
Journal:  J Clin Pathol       Date:  1988-11       Impact factor: 3.411

6.  The unexplored roles of human serum IgA.

Authors:  Ka Wai Leong; Jeak Ling Ding
Journal:  DNA Cell Biol       Date:  2014-12       Impact factor: 3.311

7.  Alpha1-microglobulin as an early biomarker of sepsis-associated acute kidney injury: a prospective cohort study.

Authors:  I Terzi; V Papaioannou; N Papanas; C Dragoumanis; A Petala; V Theodorou; T Gioka; V Vargemezis; E Maltezos; I Pneumatikos
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

Review 8.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

9.  Developmentally regulated transcription of the four liver-specific genes for inter-alpha-inhibitor family in mouse.

Authors:  J P Salier; P Chan; G Raguenez; T Zwingman; R P Erickson
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

10.  Isolation and characterization of fibronectin-alpha 1-microglobulin complex in rat plasma.

Authors:  C Falkenberg; J J Enghild; I B Thøgersen; G Salvesen; B Akerström
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.